cabazitaxel

Poland

Drugs containing this active substance

  • CABAZITAXEL EVER PHARMA

    The medicine is used to treat prostate cancer when the disease progresses despite the use of other chemotherapy.

    Form: solution for infusion, concentrate

    Active substance Dosage
    cabazitaxel 10 mg/ml

    ATC: L01CD04

    Manufacturer: EVER Pharma Jena GmbH

  • CABAZITAXEL FRESENIUS KABI

    The medicine is used to treat prostate cancer in situations where the disease progresses despite the use of other chemotherapy.

    Form: solution for infusion, concentrate

    Active substance Dosage
    cabazitaxel 20 mg/ml

    ATC: L01CD04

    Manufacturer: Fresenius Kabi Deutschland GmbH

  • CABAZITAXEL G.L.

    This medicine is used to treat prostate cancer when the disease has progressed after other chemotherapy has been used.

    Form: solution for infusion, concentrate

    Active substance Dosage
    cabazitaxel 20 mg/ml

    ATC: L01CD04

    Manufacturer: AqVida GmbH

  • CABAZITAXEL MEDICAL VALLEY

    The medicine is used to treat prostate cancer when the disease progresses despite the use of another type of chemotherapy.

    Form: solution for infusion, concentrate and solvent

    Active substance Dosage
    cabazitaxel 60 mg

    ATC: L01CD04

    Manufacturer: Pharmadox Healthcare Ltd.

  • CABAZITAXEL MSN

    The medicine is used to treat prostate cancer when the disease has been found to progress after the use of another chemotherapy.

    Form: solution for infusion, concentrate and solvent

    Active substance Dosage
    cabazitaxel 60 mg

    ATC: L01CD04

    Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.

  • ELEBER

    Eleber is used to treat prostate cancer when disease progression has been established after the use of other chemotherapy.

    Form: solution for infusion, concentrate and solvent

    Active substance Dosage
    cabazitaxel 60 mg

    ATC: L01CD04

    Manufacturer: Pharmadox Healthcare Limited